Truust Neuroimaging
San Francisco, California, United States
About Truust Neuroimaging
Their neuro-imaging products dramatically increase the resolution of existing and future neuro-imaging systems, at a fraction of the cost of equivalent hardware, and far beyond what is possible with hardware alone. Increased neuro-imaging resolution is a key enabler of new research discoveries and up-coming technologies like brain-computer interfaces, augmented cognition and artificial intelligence. Increased neuro-imaging resolution represents a leap forward in clinical diagnosis, treatment and prevention of brain-related conditions, such as epilepsy, age-related and neuro-degenerative diseases like ALS, Alzheimer’s and Parkinson’s.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Funding stage: Seed
- Last round: Seed (Sep 2015)
- Website: truustneuroimaging.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/truust-neuroimaging-2502239 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.